These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 26526578)
1. Genetic polymorphisms in MMP 2, 3, 7, and 9 genes and the susceptibility and clinical outcome of cervical cancer in a Chinese Han population. Xie B; Zhang Z; Wang H; Chen Z; Wang Y; Liang H; Yang G; Yang X; Zhang H Tumour Biol; 2016 Apr; 37(4):4883-8. PubMed ID: 26526578 [TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review. Banday MZ; Sameer AS; Mir AH; Mokhdomi TA; Chowdri NA; Haq E Gene; 2016 Sep; 589(1):81-89. PubMed ID: 27222481 [TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms in MMP 2, 3 and 9 genes and the susceptibility of osteosarcoma in a Chinese Han population. Cui Y; Zhu JJ; Ma CB; Cui K; Wang F; Ni SH; Zhang ZY Biomarkers; 2016; 21(2):160-3. PubMed ID: 26754027 [TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase variants associated with risk and clinical outcome of esophageal cancer. Zhang L; Xi RX; Zhang XZ Genet Mol Res; 2015 May; 14(2):4616-24. PubMed ID: 25966235 [TBL] [Abstract][Full Text] [Related]
5. Polymorphism of Matrix Metalloproteinases Genes MMP1, MMP2, MMP3, and MMP7 and the Risk of Varicose Veins of Lower Extremities. Shadrina AS; Smetanina MA; Sevost'yanova KS; Shevela AI; Seliverstov EI; Zakharova EA; Voronina EN; Ilyukhin EA; Zolotukhin IA; Kirienko AI; Filipenko ML Bull Exp Biol Med; 2017 Sep; 163(5):650-654. PubMed ID: 28944430 [TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion. Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112 [TBL] [Abstract][Full Text] [Related]
8. Higher risk of matrix metalloproteinase (MMP-2, 7, 9) and tissue inhibitor of metalloproteinase (TIMP-2) genetic variants to gallbladder cancer. Sharma KL; Misra S; Kumar A; Mittal B Liver Int; 2012 Sep; 32(8):1278-86. PubMed ID: 22621753 [TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk. Peng B; Cao L; Ma X; Wang W; Wang D; Yu L Mutagenesis; 2010 Jul; 25(4):371-9. PubMed ID: 20360147 [TBL] [Abstract][Full Text] [Related]
10. Association between matrix metalloproteinase gene polymorphisms and development of ischemic stroke. Hao Y; Tian S; Sun M; Zhu Y; Nie Z; Yang S Int J Clin Exp Pathol; 2015; 8(9):11647-52. PubMed ID: 26617904 [TBL] [Abstract][Full Text] [Related]
11. Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer. Woo M; Park K; Nam J; Kim JC J Gastroenterol Hepatol; 2007 Jul; 22(7):1064-70. PubMed ID: 17608852 [TBL] [Abstract][Full Text] [Related]
12. Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis. Hu C; Wang J; Xu Y; Li X; Chen H; Bunjhoo H; Xiong W; Xu Y; Zhao J Gene; 2013 Mar; 517(1):65-71. PubMed ID: 23313298 [TBL] [Abstract][Full Text] [Related]
13. The protective role of the -1306C>T functional polymorphism in matrix metalloproteinase-2 gene is associated with cervical cancer: implication of human papillomavirus infection. Singh N; Hussain S; Sharma U; Suri V; Nijhawan R; Bharadwaj M; Sobti RC Tumour Biol; 2016 Apr; 37(4):5295-303. PubMed ID: 26561467 [TBL] [Abstract][Full Text] [Related]
14. Interactions of central obesity with rs3918242 on risk of non-alcoholic fat liver disease: a preliminary case-control study. Wu P; Hua Y; Tan S; Li M; Shu Y; Fang G Int J Clin Exp Pathol; 2015; 8(4):4165-70. PubMed ID: 26097608 [TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms in MMP 2, 9 and 3 genes modify lung cancer risk and survival. González-Arriaga P; Pascual T; García-Alvarez A; Fernández-Somoano A; López-Cima MF; Tardón A BMC Cancer; 2012 Mar; 12():121. PubMed ID: 22455335 [TBL] [Abstract][Full Text] [Related]
16. The association of polymorphisms in promoter region of MMP2 and MMP9 with recurrent spontaneous abortion risk in Chinese population. Li L; Liu J; Qin S; Li R Medicine (Baltimore); 2018 Oct; 97(40):e12561. PubMed ID: 30290617 [TBL] [Abstract][Full Text] [Related]
17. MMP1, 2, 3, 7, and 9 gene polymorphisms and urinary cancer risk: a meta-analysis. Tao L; Li Z; Lin L; Lei Y; Hongyuan Y; Hongwei J; Yang L; Chuize K Genet Test Mol Biomarkers; 2015 Oct; 19(10):548-55. PubMed ID: 26301605 [TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of the matrix metalloproteinase genes are associated with essential hypertension in a Caucasian population of Central Russia. Moskalenko M; Ponomarenko I; Reshetnikov E; Dvornyk V; Churnosov M Sci Rep; 2021 Mar; 11(1):5224. PubMed ID: 33664351 [TBL] [Abstract][Full Text] [Related]
19. Association of matrix metalloproteinases (MMP2, MMP7 and MMP9) genetic variants with left ventricular dysfunction in coronary artery disease patients. Mishra A; Srivastava A; Mittal T; Garg N; Mittal B Clin Chim Acta; 2012 Oct; 413(19-20):1668-74. PubMed ID: 22664146 [TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-7 (MMP-7) polymorphism is a risk factor for endometrial cancer susceptibility. Yi YC; Chou PT; Chen LY; Kuo WH; Ho ES; Han CP; Yang SF Clin Chem Lab Med; 2010 Mar; 48(3):337-44. PubMed ID: 20113256 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]